Intravesical gemcitabine therapy for superficial transitional cell carcinoma: Results of a Phase II prospective multicenter study

Lamm, 1992, Incidence and treatment of complication of bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer, J Urol, 147, 596, 10.1016/S0022-5347(17)37316-0 Thrasher, 1992, Complications of intravesical chemotherapy, Urol Clin North Am, 19, 529, 10.1016/S0094-0143(21)00419-5 Schiller, 2002, Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer, N Engl J Med, 346, 92, 10.1056/NEJMoa011954 Burris, 1997, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer, J Clin Oncol, 15, 2403, 10.1200/JCO.1997.15.6.2403 Miura, 2001, The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranosyl)-cytosine, Jpn J Cancer Res, 92, 562, 10.1111/j.1349-7006.2001.tb01130.x Ostruszka, 2003, The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine, Cancer Chemother Pharmacol, 52, 325, 10.1007/s00280-003-0661-5 Moore, 1997, Gemcitabine, J Clin Oncol, 15, 3441, 10.1200/JCO.1997.15.12.3441 Stadler, 1997, Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer, J Clin Oncol, 15, 3394, 10.1200/JCO.1997.15.11.3394 Lorusso, 1998, A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum, Eur J Cancer, 34, 1208, 10.1016/S0959-8049(98)00030-6 Laufer, 2003, Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder, J Clin Oncol, 21, 697, 10.1200/JCO.2003.09.028 Witjes, 2004, Intravesical gemcitabine, Eur Urol, 45, 182, 10.1016/j.eururo.2003.09.014 De Beradinis, 2004, Intravesical administration of gemcitabine in superficial bladder cancer, BJU Int, 93, 491, 10.1111/j.1464-410X.2003.04656.x Dalbagni, 2002, Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder, J Clin Oncol, 20, 3193, 10.1200/JCO.2002.02.066 Oosterlinck, 2002, Guidelines on bladder cancer, Eur Urol, 41, 105, 10.1016/S0302-2838(01)00026-4 Herr, 2003, Defining bacillus Calmette-Guérin refractory superficial bladder tumors, J Urol, 169, 1706, 10.1097/01.ju.0000062605.92268.c6